Tower Research Capital LLC (Trc) Dice Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$25.86 - $46.71 $28,264 - $51,054	-1,093 Reduced 60.65%	709 $32,000
Q1 2023 May 09, 2023	BUY	$26.05 - $32.31 $35,271 - $43,747	1,354 Added 302.23%	1,802 $52,000
Q4 2022 Feb 10, 2023	SELL	$19.77 - $42.23 $15,618 - $33,361	-790 Reduced 63.81%	448 $13,000
Q3 2022 Nov 10, 2022	SELL	$14.97 - $22.65 $5,583 - $8,448	-373 Reduced 23.15%	1,238 $25,000
Q2 2022 Aug 15, 2022	SELL	$13.19 - $22.1 $3,337 - $5,591	-253 Reduced 13.57%	1,611 $25,000
Q1 2022 May 12, 2022	BUY	$14.54 - $25.02 $19,192 - $33,026	1,320 Added 242.65%	1,864 $36,000
Q4 2021 Feb 14, 2022	BUY	$22.41 - $37.54 $12,191 - $20,421	544 New	544 $14,000

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.